Examining the Sudan virus epidemic in Uganda via the use of a mobile laboratory - Scorecard - MDSpire

Examining the Sudan virus epidemic in Uganda via the use of a mobile laboratory

  • By

  • Godfrey Pimundu

  • Tonny Muyigi

  • Eunice Jennifer Nambozo

  • Christopher Okiira

  • Benedict Kanamwanji

  • Rebecca Nalwanga

  • Joseph Sekate

  • Raymond Mugabe

  • Juliet Naiga

  • Isaac Sewanyana

  • Julius Lutwama

  • Stephen Balinandi

  • Pontiano Kaleebu

  • Jane Ruth Aceng

  • Diana Atwiine

  • Henry Mwebesa

  • Henry Kyobe Bosa

  • Atek Kagirita

  • Charles Olaro

  • Andrew Nsawotebba

  • Emmanuel Achol

  • Hakim Lagu

  • Eric Nzeyimana

  • Juergen May

  • Florian Gehre

  • Muna Affara

  • Susan Nabadda

  • January 16, 2026

  • 0 min

Share

Clinical Scorecard: Examining the Sudan virus epidemic in Uganda via the use of a mobile laboratory

At a Glance

CategoryDetail
ConditionSudan Virus Disease (SVD)
Key MechanismsTransmission through direct contact with infected bodily fluids; rapid laboratory confirmation critical for treatment and containment.
Target PopulationConfirmed, probable, or suspected cases of SVD in patients of any age or sex.
Care SettingMobile laboratory deployed at Mubende Regional Referral Hospital, adjacent to the Ebola Treatment Unit.

Key Highlights

  • Uganda's sixth Ebola outbreak declared on September 20, 2022, caused by Sudan virus.
  • Mobile laboratory deployed to reduce turnaround time for laboratory diagnostics.
  • Average processing of 25 samples per day with two mobile gloveboxes for efficiency.
  • First outbreak in Uganda occurred in 2000 with a case fatality rate of 53%.
  • Integration of mobile laboratory with existing facilities to enhance outbreak response.

Guideline-Based Recommendations

Diagnosis

  • Rapid confirmation of SVD through laboratory diagnostic methods is essential.

Management

  • Supportive treatment initiated upon laboratory confirmation.

Monitoring & Follow-up

  • Continuous monitoring of laboratory results to inform patient care and outbreak response.

Risks

  • High case fatality rate and potential for rapid spread in outbreak settings.

Patient & Prescribing Data

Patients with confirmed, probable, or suspected SVD.

Timely laboratory results critical for initiating appropriate supportive care.

Clinical Best Practices

  • Ensure rapid laboratory diagnostics to facilitate timely outbreak response.
  • Maintain strict biosafety and biosecurity protocols in mobile laboratory operations.
  • Utilize trained personnel for continuous operation of mobile laboratories.

References

Original Source(s)

Examining the Sudan virus epidemic in Uganda via the use of a mobile laboratory

  • by Godfrey Pimundu, Tonny Muyigi, Eunice Jennifer Nambozo, Christopher Okiira, Benedict Kanamwanji, Rebecca Nalwanga, Joseph Sekate, Raymond Mugabe, Juliet Naiga, Isaac Sewanyana, Julius Lutwama, Stephen Balinandi, Pontiano Kaleebu, Jane Ruth Aceng, Diana Atwiine, Henry Mwebesa, Henry Kyobe Bosa, Atek Kagirita, Charles Olaro, Andrew Nsawotebba, Emmanuel Achol, Hakim Lagu, Eric Nzeyimana, Juergen May, Florian Gehre, Muna Affara, Susan Nabadda

  • January 16, 2026

Related Content

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.

Amputation Rates Rose in Opioid-Related Hospitalizations

National inpatient analysis found steeper increases in amputations during opioid-related hospitalizations, particularly in the Northeast and West.

Nancy Cox, influential figure in global influenza research and former CDC leader, passes away at 77